10x Genomics Inc Class A
(NASDAQ: TXG)

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.

17.770

-0.380 (-2.09%)
Range 17.390 - 18.200   (4.66%)
Open 18.160
Previous Close 18.150
Bid Price 52.680
Bid Volume 10
Ask Price 53.310
Ask Volume 8
Volume 1,789,778
Value -
Remark
Delayed prices. Updated at 06 Dec 2025 05:00.
Data powered by
View All Events


Loading Chart...

Please login to view stock data and analysis